vs
California Resources Corp（CRC）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
California Resources Corp的季度营收约是Royalty Pharma plc的1.1倍（$679.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 1.8%，领先32.7%），Royalty Pharma plc同比增速更快（4.8% vs -17.8%），过去两年California Resources Corp的营收复合增速更高（25.8% vs 4.6%）
加州资源集团是一家美国能源企业，主要在加州开展油气勘探业务。公司注册地为特拉华州，总部位于加州长滩，所持有的加州矿产地块面积是该州私有主体中的最高水平。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CRC vs RPRX — 直观对比
营收规模更大
CRC
是对方的1.1倍
$622.0M
营收增速更快
RPRX
高出22.6%
-17.8%
净利率更高
RPRX
高出32.7%
1.8%
两年增速更快
CRC
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $679.0M | $622.0M |
| 净利润 | $12.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 6.9% | 62.4% |
| 净利率 | 1.8% | 34.4% |
| 营收同比 | -17.8% | 4.8% |
| 净利润同比 | -63.6% | 2.9% |
| 每股收益（稀释后） | $0.21 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRCRPRX
| Q4 25 | $679.0M | $622.0M | ||
| Q3 25 | $715.0M | $609.3M | ||
| Q2 25 | $702.0M | $578.7M | ||
| Q1 25 | $814.0M | $568.2M | ||
| Q4 24 | $826.0M | $593.6M | ||
| Q3 24 | $870.0M | $564.7M | ||
| Q2 24 | $412.0M | $537.3M | ||
| Q1 24 | $429.0M | $568.0M |
净利润CRCRPRX
| Q4 25 | $12.0M | $214.2M | ||
| Q3 25 | $64.0M | $288.2M | ||
| Q2 25 | $172.0M | $30.2M | ||
| Q1 25 | $115.0M | $238.3M | ||
| Q4 24 | $33.0M | $208.2M | ||
| Q3 24 | $345.0M | $544.0M | ||
| Q2 24 | $8.0M | $102.0M | ||
| Q1 24 | $-10.0M | $4.8M |
营业利润率CRCRPRX
| Q4 25 | 6.9% | 62.4% | ||
| Q3 25 | 13.7% | 70.1% | ||
| Q2 25 | 38.0% | 36.3% | ||
| Q1 25 | 22.9% | 94.0% | ||
| Q4 24 | 8.2% | 60.9% | ||
| Q3 24 | 59.5% | — | ||
| Q2 24 | 9.2% | 50.2% | ||
| Q1 24 | -0.9% | -13.0% |
净利率CRCRPRX
| Q4 25 | 1.8% | 34.4% | ||
| Q3 25 | 9.0% | 47.3% | ||
| Q2 25 | 24.5% | 5.2% | ||
| Q1 25 | 14.1% | 41.9% | ||
| Q4 24 | 4.0% | 35.1% | ||
| Q3 24 | 39.7% | 96.3% | ||
| Q2 24 | 1.9% | 19.0% | ||
| Q1 24 | -2.3% | 0.8% |
每股收益（稀释后）CRCRPRX
| Q4 25 | $0.21 | $0.49 | ||
| Q3 25 | $0.76 | $0.67 | ||
| Q2 25 | $1.92 | $0.07 | ||
| Q1 25 | $1.26 | $0.55 | ||
| Q4 24 | $0.87 | $0.46 | ||
| Q3 24 | $3.78 | $1.21 | ||
| Q2 24 | $0.11 | $0.23 | ||
| Q1 24 | $-0.14 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $132.0M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.7B | $9.7B |
| 总资产 | $7.4B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CRCRPRX
| Q4 25 | $132.0M | $618.7M | ||
| Q3 25 | $196.0M | $938.9M | ||
| Q2 25 | $72.0M | $631.9M | ||
| Q1 25 | $214.0M | $1.1B | ||
| Q4 24 | $372.0M | $929.0M | ||
| Q3 24 | $241.0M | $950.1M | ||
| Q2 24 | $1.0B | $1.8B | ||
| Q1 24 | $403.0M | $843.0M |
总债务CRCRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | $1.0B | $8.9B | ||
| Q2 25 | $1.0B | $8.0B | ||
| Q1 25 | $1.0B | $7.6B | ||
| Q4 24 | $1.1B | $7.6B | ||
| Q3 24 | $1.1B | $7.6B | ||
| Q2 24 | $1.2B | $7.6B | ||
| Q1 24 | $541.0M | $6.1B |
股东权益CRCRPRX
| Q4 25 | $3.7B | $9.7B | ||
| Q3 25 | $3.4B | $9.6B | ||
| Q2 25 | $3.4B | $9.5B | ||
| Q1 25 | $3.5B | $9.8B | ||
| Q4 24 | $3.5B | $10.3B | ||
| Q3 24 | $3.5B | $10.3B | ||
| Q2 24 | $2.1B | $9.8B | ||
| Q1 24 | $2.1B | $9.9B |
总资产CRCRPRX
| Q4 25 | $7.4B | $19.6B | ||
| Q3 25 | $6.8B | $19.3B | ||
| Q2 25 | $6.7B | $18.3B | ||
| Q1 25 | $6.8B | $17.6B | ||
| Q4 24 | $7.1B | $18.2B | ||
| Q3 24 | $7.1B | $18.0B | ||
| Q2 24 | $4.5B | $17.7B | ||
| Q1 24 | $3.9B | $16.1B |
负债/权益比CRCRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | 0.29× | 0.93× | ||
| Q2 25 | 0.30× | 0.84× | ||
| Q1 25 | 0.29× | 0.78× | ||
| Q4 24 | 0.32× | 0.74× | ||
| Q3 24 | 0.32× | 0.74× | ||
| Q2 24 | 0.57× | 0.78× | ||
| Q1 24 | 0.26× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $235.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $115.0M | — |
| 自由现金流率自由现金流/营收 | 16.9% | — |
| 资本支出强度资本支出/营收 | 17.7% | — |
| 现金转化率经营现金流/净利润 | 19.58× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $543.0M | — |
8季度趋势，按日历期对齐
经营现金流CRCRPRX
| Q4 25 | $235.0M | $827.1M | ||
| Q3 25 | $279.0M | $702.6M | ||
| Q2 25 | $165.0M | $364.0M | ||
| Q1 25 | $186.0M | $596.1M | ||
| Q4 24 | $206.0M | $742.5M | ||
| Q3 24 | $220.0M | $703.6M | ||
| Q2 24 | $97.0M | $658.2M | ||
| Q1 24 | $87.0M | $664.6M |
自由现金流CRCRPRX
| Q4 25 | $115.0M | — | ||
| Q3 25 | $188.0M | — | ||
| Q2 25 | $109.0M | — | ||
| Q1 25 | $131.0M | — | ||
| Q4 24 | $118.0M | — | ||
| Q3 24 | $141.0M | — | ||
| Q2 24 | $63.0M | — | ||
| Q1 24 | $33.0M | — |
自由现金流率CRCRPRX
| Q4 25 | 16.9% | — | ||
| Q3 25 | 26.3% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 14.3% | — | ||
| Q3 24 | 16.2% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | 7.7% | — |
资本支出强度CRCRPRX
| Q4 25 | 17.7% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 12.6% | — |
现金转化率CRCRPRX
| Q4 25 | 19.58× | 3.86× | ||
| Q3 25 | 4.36× | 2.44× | ||
| Q2 25 | 0.96× | 12.06× | ||
| Q1 25 | 1.62× | 2.50× | ||
| Q4 24 | 6.24× | 3.57× | ||
| Q3 24 | 0.64× | 1.29× | ||
| Q2 24 | 12.13× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRC
| Oil And Natural Gas Segment | $645.0M | 95% |
| Natural Gas Production | $26.0M | 4% |
| Other | $7.0M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
